TLRY
Get informed when a big investor buys or sells
+ FollowOvervalued by 144.3% based on the discounted cash flow analysis.
| Market cap | $562.51 Million |
|---|---|
| Enterprise Value | $715.78 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.09 |
| Beta | 1.92 |
| Outstanding Shares | 133,340,533 |
| P/E Ratio | -2.15 |
|---|---|
| PEG | -0.02 |
| Price to Sales | 0.46 |
| Price to Book Ratio | 0.27 |
| Enterprise Value to Revenue | 0.75 |
| Enterprise Value to EBIT | -16.79 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.52 |
| Debt to Equity | 0.23 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 74.42% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 12.38% |
|---|---|
| Total Invested | $12,477▼ 99.98% |
| Investors Holding | 9▼ 247.00% |
No data
Tilray Brands, Inc. operates as a consumer lifestyle company primarily involved in the research, cultivation, manufacturing, and worldwide supply of medical cannabis products. Its expansive global footprint includes Canada, the United St...